Lupin gets tentative FDA approval for COPD drug, famotidine approved
NewsBytes | May 19, 2026 3:39 AM CST
Approvals strengthen Lupin US market presence
Revefenacin matches Mylan's Yupelri, which made $260.7 million in US sales in IQVIA MAT March 2026, so it is a pretty big deal.
The famotidine injection, made at their Nagpur facility, is similar to Merck's Pepcid and brought in $8.7 million.
These approvals help Lupin strengthen its presence in the competitive US pharmaceutical market.
READ NEXT
-
Recipe : This time, not from dal, but from potato, make crispy meduvade quickly, note the recipe
-
Sunglasses For Summer: If you want to look stylish while protecting yourself from the sun in summer, then try these trendy sunglasses.
-
Aloe Vera Juice: Benefits and Precautions
-
Important meeting of Mohan Cabinet today in Bhopal, new transfer policy 2026 may get approval
-
Big news came early in the morning for petrol and diesel customers, after last week’s shock, companies took this decision today.
